Month: September 2016

BUHLMANN Highlights: Neuroimmune Biomarkers, Esoteric Testing, and Utilization in Research

BÜHLMANN Neuroimmunology Assays Simple, Esoteric Testing for Important Neuroimmune Biomarkers The BÜHLMANN Neuroimmunology product line is a list of robust assays for simple, esoteric testing for important neuroimmune biomarkers and it is supported by numerous clinical publications.  Learn More About: Benefits, Features and Highlights of BÜHLMANN Neuroimmunology Assays BÜHLMANN Assay Kit Citations- See how these assays were used
Continue Reading

CAL-101, A p110delta Selective Phosphatidylinositol-3-Kinase Inhibitor for the Treatment of B-cell Malignancies, Inhibits PI3K Signaling and Cellular Viability

Flow CAST® - Kinase Inhibtion Assay Citation: Lannutti, B.J. et al. CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood. 2011 Jan 13; 117(2): 591-594. PMID: 20959606. "We have thus described the biochemical and cellular activity of CAL-101, a selective and potent inhibitor of p110δ; such targeted
Continue Reading

A Novel Turbidimetric Immunoassay for Fecal Calprotectin Optimized for Routine Chemistry Analyzers

BÜHLMANN fCAL® turbo Citation: Nilsen, T. et. al.  A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers. J Clin Lab Anal. 2016 Sep 15. PMID:27629827 The publication describes the technical performance of the turbidimetric assay on the cobas c501 and the Mindray BS-380. Highlight from this Publication Short assay time of 10 min with
Continue Reading

Review BUHLMANN Products- Get $20 Amazon Gift Card

Are you using BÜHLMANN products and want to leave a comment on Biocompare? BÜHLMANN offers a wide variety of products including ELISA kits, RIA  kits, lateral flow assays, flow cytometry assays and turbidimetric assays. If you have used any of the assays in our product portfolio please share your experience with researchers around the world and you
Continue Reading

BUHLMANN announces new Microsite for Kinase Inhibition Assay

BÜHLMANN’s Kinase Inhibition Assay Testing Potency and Efficacy of Inhibitors of PI3K δ, PI3K γ, BTK and SYK Activity Biomarker assays are developed specifically for pharmacokinetic and pharmacodyamic (PK/PD) models during drug discovery and are often used to test efficacy and toxicity. Inhibitors of PI3K, BTK and SYK pathways are a large focus for pharmaceutical
Continue Reading

High-Dose Rituximab and Anti-MAG-Associated Polyneuropathy

Anti-MAG Autoantibodies ELISA Citation: Renaud S et al.; High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology. 2006 Mar 14; 66(5):742-4. PMID:16534115

Continue Reading

Anti-Myelin-Associated Glycoprotein Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Steck AJ et al.; Anti-myelin-associated glycoprotein neuropathy; Curr Opin Neurol. 2006 Oct; 19(5): 458-63. Review. PMID:16969155

Continue Reading

Further Comparisons of Assays for Detecting MAG IgM Autoantibodies

Anti-MAG Autoantibodies ELISA Citation: Jaskowski TD et al.; Further comparisons of assays for detecting MAG IgM autoantibodies; J Neuroimmunol. 2007 Jul; 187(1-2): 175-8. PMID:17537521 Highlight from this Publication “EIA detected low titers of MAG IgM antibodies in suspected [subject] sera (negative by other methods) that were also SGPG IgM-positive.” Read Citation
Continue Reading

Detection of Anti-MAG Antibodies in Polyneuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citation: Kuijf ML et al.; Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology. 2009 Sep 1; 73(9): 688-95. PMID:19720975

Continue Reading
Sign Up for BUHLMANN Updates!

Enter your email and stay on top of things,